cbcbc1971 Profile Banner
Byoung Chul Cho, M.D., Ph.D. Profile
Byoung Chul Cho, M.D., Ph.D.

@cbcbc1971

Followers
84
Following
4
Media
4
Statuses
9

Professor, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine

Seoul, Rep. of Korea
Joined August 2021
Don't wanna be here? Send us removal request.
@cbcbc1971
Byoung Chul Cho, M.D., Ph.D.
3 years
Today, we presented new preclinical #data supporting intracranial activity of NVL-655 at #AACR23. Thank you to our collaborators Dr. Cho @cbcbc1971 and his group at Yonsei University College of Medicine.
0
0
1
@cbcbc1971
Byoung Chul Cho, M.D., Ph.D.
7 months
ESMO TAT Asia 2025 초록 모집 안내 (~4/29 마감) ESMO TAT (Targeted Anticancer Therapies) Asia Congress 2025 (7/18~7/20) 홍콩에서 개최됩니다. [ESMO Targeted Anticancer Therapies Asia Congress 2025 - Submit your abstract] https://t.co/QK4ovhQ8cA
0
0
0
@nuvalent
Nuvalent
3 years
Today, we presented new preclinical #data supporting intracranial activity of NVL-655 at #AACR23. Thank you to our collaborators Dr. Cho @cbcbc1971 and his group at Yonsei University College of Medicine. https://t.co/m0bnqsZ7jL
0
5
14
@oncoOuLungCA
Sai-Hong Ignatius Ou
3 years
Repotrectinib data presented by @cbcbc1971 . #ena2022 #ROS1
0
2
3
@drruchibhatt
Dr. Ruchi Dass
3 years
On National Lung Cancer Screening Day, I would like to thank and support the efforts of Byoung Chul Cho @cbcbc1971 & his study -Novel drug for #LungCancer showing promise in early-stage clinical trials @marjoriezettler Learn how @qure_ai is working for the cause. #RSNA22
0
9
27
@HHorinouchi
Hidehito HORINOUCHI
3 years
@cbcbc1971 nicely overviewed antibody-drug conjugates (ADCs), bispecific antibodies. T-DXd, Dato-DXd, HER3-DXd, Teliso-V, Amivantamab, and Tarlatamab, etc. #LCSM #TASLC
0
1
2
@cbcbc1971
Byoung Chul Cho, M.D., Ph.D.
4 years
0
0
1
@cbcbc1971
Byoung Chul Cho, M.D., Ph.D.
4 years
Looking forward to seeing you at #WCLC2021!! If anyone else is interested in Antibody–Drug Conjugates in #lungcancer, Please come to the education session ES04 at @WCLC2021 on Sep 10.
0
1
1
@cbcbc1971
Byoung Chul Cho, M.D., Ph.D.
4 years
Looking forward to seeing you at #WCLC2021!! If anyone else is interested in Antibody–Drug Conjugates in #lungcancer, Please come to the education session ES04 at @WCLC2021 on Sep 10.
0
1
1